Naoya Inoue Selected Research

Naoya Inoue Research Topics

Disease

19	Thyroid Diseases (Thyroid Disease) 09/2023 - 10/2013
9	Graves Disease (Basedow Disease) 04/2024 - 05/2009
9	Hashimoto Disease (Thyroiditis, Hashimoto) 05/2020 - 05/2009
6	Neoplasms (Cancer) 01/2023 - 08/2002
4	Neoplasm Metastasis (Metastasis) 08/2020 - 01/2011
3	Autoimmune Diseases (Autoimmune Disease) 09/2023 - 01/2016
3	Inflammation (Inflammations) 01/2023 - 01/2016
2	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2022 - 11/2012
1	Stroke (Strokes) 01/2024
1	Heart Failure 01/2024
1	Myocardial Infarction 01/2024
1	Coronary Artery Disease (Coronary Atherosclerosis) 08/2023
1	Acute Coronary Syndrome 08/2023
1	Intracranial Embolism 09/2022
1	Pulmonary Hypertension 09/2022
1	Pulmonary Arterial Hypertension 09/2022
1	Sarcoidosis (Schaumann Disease) 09/2022
1	Cerebral Infarction 09/2022
1	Nausea 01/2022
1	Vomiting 01/2022
1	Thyroiditis 11/2021
1	Pathologic Processes 04/2016
1	Rectal Neoplasms (Rectal Cancer) 01/2015
1	Immunoglobulin G4-Related Disease 10/2013
1	Biliary Tract Neoplasms (Biliary Tract Cancer) 06/2011
1	Gastrinoma 03/2011
1	Hyperplasia 03/2011
1	Stomach Neoplasms (Stomach Cancer) 01/2011
1	Lymphatic Metastasis 01/2011
1	Hypothyroidism 05/2009
1	Esophageal Squamous Cell Carcinoma 01/2006
1	Colonic Neoplasms (Colon Cancer) 01/2003

Drug/Important Bio-Agent (IBA)

4	Interleukin-10 (Interleukin 10)IBA 04/2024 - 10/2013
3	MicroRNAs (MicroRNA)IBA 08/2017 - 04/2016
2	Proteins (Proteins, Gene)FDA Link 01/2023 - 02/2020
2	LigandsIBA 11/2021 - 01/2006
2	Cetuximab (Erbitux)FDA Link 08/2020 - 08/2015
2	Bevacizumab (Avastin)FDA Link 08/2020 - 08/2015
2	Iodide Peroxidase (Deiodinase)IBA 07/2018 - 10/2017
2	Interleukin-12 (IL 12)IBA 07/2017 - 08/2002
2	DNA (Deoxyribonucleic Acid)IBA 02/2015 - 03/2012
1	omega-Chloroacetophenone (Mace)IBA 01/2024
1	Histones (Histone)IBA 09/2023
1	LipidsIBA 08/2023
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 08/2023
1	C-Reactive ProteinIBA 01/2023
1	N-benzyl-N,1-dimethyl-2-propynylamineIBA 01/2023
1	benzimidazoleIBA 01/2023
1	selexipagIBA 09/2022
1	Streptozocin (Streptozotocin)FDA Link 01/2022
1	AntiemeticsIBA 01/2022
1	Vitamin A (Retinol)FDA LinkGeneric 11/2021
1	Retinoic Acid 4-Hydroxylase (CYP26B1)IBA 11/2021
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2020
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 05/2020
1	Interleukin-6 (Interleukin 6)IBA 11/2019
1	Thyroglobulin FDA Link 09/2017
1	InterleukinsIBA 08/2017
1	Interleukin-18 (Interleukin 18)IBA 07/2017
1	Biomarkers (Surrogate Marker)IBA 05/2017
1	Toll-Like Receptors (Toll-Like Receptor)IBA 05/2017
1	AntibodiesIBA 01/2017
1	Type I Tumor Necrosis Factor ReceptorsIBA 10/2016
1	Type II Tumor Necrosis Factor ReceptorsIBA 10/2016
1	Interleukin-8 (Interleukin 8)IBA 01/2016
1	Chemotactic FactorsIBA 01/2016
1	Histone Deacetylases (Histone Deacetylase)IBA 01/2016
1	NAD (NADH)IBA 01/2016
1	ChemokinesIBA 01/2016
1	Chemokine CCL5IBA 01/2016
1	Interleukin-16 (Interleukin 16)IBA 01/2016
1	Sirtuin 1IBA 01/2016
1	CytokinesIBA 10/2013
1	Immunoglobulin G (IgG)IBA 10/2013
1	Gemcitabine FDA Link 06/2011
1	S 1 (combination)IBA 06/2011
1	phorbol 12-pyrenebutyrate 13-(3,3,3-trifloro-2-diazopropioate)IBA 03/2011
1	Nimodipine (Modus)FDA LinkGeneric 03/2011
1	Somatostatin Receptors (Somatostatin Receptor)IBA 03/2011
1	CalciumIBA 03/2011
1	SecretagoguesIBA 03/2011
1	SolutionsIBA 03/2011
1	Secretin FDA Link 03/2011
1	Long-Acting Thyroid Stimulator (LATS)IBA 05/2009
1	Thyroxine (Levothyroxine)FDA LinkGeneric 05/2009
1	Interleukin-4 (Interleukin 4)IBA 05/2009
1	Cisplatin (Platino)FDA LinkGeneric 01/2006
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2006
1	AntigensIBA 01/2003
1	Mitomycin (Mitomycin-C)FDA LinkGeneric 01/2003

Therapy/Procedure

5	Drug Therapy (Chemotherapy) 08/2015 - 01/2003
3	Therapeutics 01/2023 - 08/2002
1	Percutaneous Coronary Intervention 08/2023
1	Hepatectomy 08/2020
1	Neoadjuvant Therapy 01/2015
1	Pancreaticoduodenectomy 03/2011
1	Pancreatectomy 03/2011
1	Gastrectomy 01/2011
1	Lymph Node Excision (Lymph Node Dissection) 01/2011
1	Combination Drug Therapy (Combination Chemotherapy) 01/2011